Abstract
A detailed patient-by-patient costing analysis, based on case records for 253 patients diagnosed in 1993, reveals that the mean 4-year diagnosis and management costs amounted to £6150 and £5668 for non-small cell and small cell lung cancer respectively. These costs are lower than those identified in Canadian studies, the difference being explained by the use of a simulated costing methodology in these studies, lower unit costs and less aggressive interventions.
Author supplied keywords
Cite
CITATION STYLE
Wolstenholme, J. L., & Whynes, D. K. (1999). The hospital costs of treating lung cancer in the United Kingdom. British Journal of Cancer, 80(1–2), 215–218. https://doi.org/10.1038/sj.bjc.6690341
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.